参考文献:Assana E, Kyngdon CT, Gauci CG, Geerts S, Dorny P, De Deken R (2010) Elimination of Taenia solium transmission to pigs in a field trial of the HP6/TSOL18 vaccine in Cameroon. Int J Parasitol 40:515–519PubMedCentral CrossRef PubMed Aviezer D, Brill-Almon E, Shaaltiel Y, Hashmueli S, Bartfeld D, Mizrachi S, Liberman Y, Freeman A, Zimran A, Galun E (2009) A plant-derived recombinant human glucocerebrosidase enzyme—a preclinical and phase I investigation. PLoS One 4:e4792PubMedCentral CrossRef PubMed Batson A (1998) Win–win interactions between the public and private sectors. Nat Med 4(5 Suppl):487–491CrossRef PubMed Benitez L, Garate T, Harrison LJ, Kirkham P, Brookes SM, Parkhouse RM (1996) Cloning and sequencing of the gene encoding the principal 18-kDa a secreted antigen of activated oncospheres of Taenia saginata. Mol Biochem Parasitol 78:265–268CrossRef PubMed Berman S, Giffin RB (2004) Global perspectives on vaccine financing. Expert Rev Vaccines 3:557–562CrossRef PubMed Betancourt MA, de Aluja AS, Sciutto E, Hernández M, Bobes RJ, Rosas G, Hernández B, Fragoso G, Hallal-Calleros C, Aguilar L, Flores-Peréz I (2012) Effective protection induced by three different versions of the porcine S3Pvac anticysticercosis vaccine against rabbit experimental Taenia pisiformis cysticercosis. Vaccine 30:2760–2767CrossRef PubMed Cai X, Yuan G, Zheng Y, Luo X, Zhang S, Ding J, Jing Z, Lu C (2008) Effective production and purification of the glycosylated TSOL18 antigen, which is protective against pig cysticercosis. Infect Immun 76:767–770PubMedCentral CrossRef PubMed Dabral N, Moreno-Lafont M, Sriranganathan N, Vemulapalli R (2014) Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308. PLoS One 9(9):e107180PubMedCentral CrossRef PubMed Daniell H (2006) Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol J 1:1071–1079CrossRef PubMed De Aluja AS (2008) Cysticercosis in the pig. Curr Trop Med Chem 8:368–374CrossRef De Aluja AS, Suárez-Marín R, Sciutto-Conde E, Morales-Soto J, Martínez-Maya JJ, Villalobos N (2014) Evaluation of the impact of a control program against taeniasis-cysticercosis (Taenia solium). Salud Publica Mex 56:259–265PubMed Dellaporta SL, Wood J, Hicks JB (1983) A plant DNA minipreparation: version II. Plant Mol Biol Rep 1:19–21CrossRef Flisser A, Gauci CG, Zoli A, Martinez-Ocana J, Garza-Rodriguez A, Dominguez-Alpizar JL, Maravilla P, Rodriguez-Canul R, Ávila G, Aguilar-Vega L, Kyngdon C, Geerts S, Lightowlers MW (2004) Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun 72:5292–5297PubMedCentral CrossRef PubMed Fragoso G, Esquivel-Guadarrama F, Santana MA, Bobes RJ, Hernández B, Cervantes J, Segura R, Goldbaum FA, Sciutto E, Rosas G (2011) Heterologous prime-boost oral immunization with GK1 peptide from Taenia crassiceps cysticerci induces protective immunity. Clin Vaccine Immunol 18:1067–1076PubMedCentral CrossRef PubMed Gandhi G, Lydonb P, Cornejoc S, Brenzel L, Wrobel S, Chang H (2013) Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011–2020. Vaccine 31:137–148CrossRef Garcia HH, Del Brutto OH, Cysticercosis Working Group in Peru (2005) Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 4:653–661CrossRef PubMed Gauci CG, Flisser A, Lightowlers MW (1998) Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18 kDa antigens. Int J Parasitol 28:757–760CrossRef PubMed Gecchele E, Merlin M, Brozzetti A, Falorni A, Pezzotti M, Avesani L (2015) A comparative analysis of recombinant protein expression in different biofactories: bacteria, insect cells and plant systems. J Vis Exp 97:e52459. doi:10.3791/52459 Gonzalez AE, Gauci CG, Barber D, Gilman RH, Tsang VC, Garcia HH, Verastegui M, Lightowlers MW (2005) Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg 72:837–839PubMed Harrison GB, Heath DD, Dempster RP, Gauci C, Newton SE, Cameron WG, Robinson CM, Lawrence SB, Lightowlers MW, Rickard MD (1996) Identification and cDNA cloning of two novel low molecular weight host-protective antigens from Taenia ovis oncospheres. Int J Parasitol 26:195–204CrossRef PubMed Hernández M, Cabrera-Ponce JL, Fragoso G, López-Casillas F, Guevara-García A, Rosas G, León-Ramírez C, Juárez P, Sánchez-García G, Cervantes J, Acero G, Toledo A, Cruz C, Bojalil R, Herrera-Estrella L, Sciutto E (2007) A new highly effective anticysticercosis vaccine expressed in transgenic papaya. Vaccine 25:4252–4260CrossRef PubMed Hernández M, Rosas G, Cervantes J, Fragoso G, Rosales-Mendoza S, Sciutto E (2014) Transgenic plants: a 5-year update on oral antipathogen vaccine development. Expert Rev Vaccines 13:1523–1536CrossRef PubMed Huerta M, De Aluja AS, Fragoso G, Toledo A, Villalobos N, Hernández M, Gevorkian G, Acero G, Diaz A, Alvarez I, Avila R, Beltran C, Garcia G, Martinez JJ, Larralde C, Sciutto E (2001) Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine 20:262–266CrossRef PubMed Jayashi CM, Gonzalez AE, Castillo Neyra R, Kyngdon CT, Gauci CG, Lightowlers MW (2012) Characterisation of antibody responses in pigs induced by recombinant oncosphere antigens from Taenia solium. Vaccine 30:7475–7480CrossRef PubMed Kim SI, Veena JH, Gelvin SB (2007) Genome-wide analysis of Agrobacterium T-DNA integration sites in the Arabidopsis genome generated under non-selective conditions. Plant J 51:779–791CrossRef PubMed Larralde C, Sciutto E (2006) El control de la Taenia solium en México quinientos años después de su llegada al Nuevo Mundo. Cisticercosis, guía para profesionales de la salud. Secretaría de Salud, Fundación Mexicana para la Salud, Instituto Nacional de Salud Pública, Fondo de Cultura Económica 7:182–237. ISBN 968-16- 8138-X Lightowlers MW (2006) Cestode vaccines: origins, current status and future prospects. Parasitology 133:27–42CrossRef Marquet-Blouin E, Bouche FB, Steinmetz A, Muller CP (2003) Neutralizing immunogenicity of transgenic carrot (Daucus carota L.) derived measles virus hemagglutinin. Plant Mol Biol 51:459–469CrossRef PubMed Mojica-Henshaw MP, Francisco AD, De Guzman F, Tigno XT (2003) Possible immunomodulatory actions of Carica papaya seed extract. Clin Hemorheol Microcirc 29:219–229PubMed Molina A, Veramendi J, Hervás-Stubbs S (2005) Induction of neutralizing antibodies by a tobacco chloroplast-derived vaccine based on a B cell epitope from canine parvovirus. Virology 342:266–275CrossRef PubMed Molinari JL, Soto R, Tato P, Rodriguez D, Retana A, Sepulveda J, Palet A (1993) Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study. Am J Trop Med Hyg 49:502–512PubMed Molinari JL, Rodriguez D, Tato P, Soto R, Arechavaleta F, Solano S (1997) Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs. Vet Parasitol 69:55–63CrossRef PubMed Morales J, Martínez JJ, Manoutcharian K, Hernández M, Fleury A, Gevorkian G, Acero G, Blancas A, Toledo A, Cervantes J, Maza V, Quet F, Bonnabau H, De Aluja AS, Fragoso G, Larralde C, Sciutto E (2008) Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. Vaccine 26:2899–2905CrossRef PubMed Murashige T, Skoog F (1962) A revised medium for rapid growth and bioassays with tobacco tissue culture. Physiol Plant 15:473–479CrossRef Parkhouse RM, Bonay P, González LM, Ferrer E, Gárate T, Aguilar CM, Cortez AMM, Harrison LJ (2008) TSOL18/HP6-Tsol, an immunogenic Taenia solium oncospheral adhesion protein and potential protective antigen. Parasitol Res 102:921–926CrossRef PubMed Rosales-Mendoza S, Salazar-González JA (2014) Immunological aspects of using plant cells as delivery vehicles for oral vaccines. Expert Rev Vaccines 13:737–749CrossRef PubMed Rosales-Mendoza S, Tello-Olea MA (2015) Carrot cells: a pioneering platform for biopharmaceuticals production. Mol Biotechnol 57:219–232CrossRef PubMed Rosales-Mendoza S, Soria-Guerra RE, de Jesús Olivera-Flores MT, López-Revilla R, Argüello-Astorga GR, Jiménez-Bremont JF, García-de la Cruz RF, Loyola-Rodríguez JP, Alpuche-Solís AG (2007) Expression of Escherichia coli heat-labile enterotoxin b subunit (LTB) in carrot (Daucus carota L.). Plant Cell Rep 26:969–976CrossRef PubMed Rosales-Mendoza S, Soria-Guerra RE, López-Revilla R, Moreno-Fierros L, Alpuche-Solís AG (2008) Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Rep 1:79–84 Rosales-Mendoza S, Soria-Guerra RE, Moreno-Fierros L, Han Y, Alpuche-Solís AG, Korban SS (2011) Transgenic carrot tap roots expressing an immunogenic F1-V fusion protein from Yersinia pestis are immunogenic in mice. J Plant Physiol 168:174–180CrossRef PubMed Rosas G, Cruz-Revilla C, Fragoso G, López-Casillas F, Pérez A, Bonilla MA, Rosales R, Sciutto E (1998) Taenia crassiceps cysticercosis: humoral immune response and protection elicited by DNA immunization. J Parasitol 84:516–523CrossRef PubMed Sciutto E, Morales J, Martinez JJ, Toledo A, Villalobos MN, Cruz-Revilla C, Meneses G, Hernández M, Diaz A, Rodarte LF, Acero G, Gevorkian G, Manoutcharian K, Paniagua J, Fragoso G, Fleury A, Larralde R, De Aluja AS, Larralde C (2007) Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico. Parasitology 134:129–133CrossRef PubMed Sciutto E, Fragoso G, de Aluja AS, Hernández M, Rosas G, Larralde C (2008) Vaccines against cysticercosis. Curr Top Med Chem 8:415–423CrossRef PubMed Sciutto E, Fragoso G, Hernández M, Rosas G, Martinez JJ, Fleury A, Cervantes J, Aluja A, Larralde C (2013) Development of the S3pvac vaccine against murine Taenia crassiceps cysticercosis: a historical review. J Parasitol 99:693–702CrossRef PubMed Streatfield SJ, Howard JA (2003) Plant production systems for vaccines. Expert Rev Vaccines 2:763–775CrossRef PubMed Toledo A, Larralde C, Fragoso G, Gevorkian G, Manoutcharian K, Hernández M, Acero G, Rosas G, López-Casillas F, Garfias CK, Vázquez R, Terrazas I, Sciutto E (1999) Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis. Infect Immun 67:2522–2530PubMedCentral PubMed Toledo A, Fragoso G, Rosas G, Hernández M, Gevorkian G, López-Casillas F, Hernández B, Acero G, Huerta M, Larralde C, Sciutto E (2001) Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response. Infect Immun 69:1766–1773PubMedCentral CrossRef PubMed Wang QM, Sun SH, Hu ZL, Wu D, Wang ZC (2003) Immune response and protection elicited by DNA immunization against Taenia cysticercosis. Vaccine 21:1672–1680CrossRef PubMed Webster DE, Smith SD, Pickering RJ, Strugnell RA, Dry IB, Wesselingh SL (2006) Measles virus hemagglutinin protein expressed in transgenic lettuce induces neutralising antibodies in mice following mucosal vaccination. Vaccine 24:3538–3544CrossRef PubMed Weng H, Pan A, Yang L, Zhang C, Liu Z, Zhang D (2004) Estimating number of transgene copies in transgenic rapeseed by real-time PCR assay with HMG I/Y as an endogenous reference gene. Plant Mol Biol Rep 22:289–300CrossRef Wu L, Diao Z, Dengm X, Gao J, Zhou Z, Liu Y, Wang Y (2005) DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium. J Nanosci Nanotechnol 5:1204–1210CrossRef PubMed Yusibov V, Streatfield SJ, Kushnir N (2011) Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies, and beyond. Hum Vaccin 7:313–321CrossRef PubMed
1. Laboratorio de Biofarmacéuticos Recombinantes, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, 78210, San Luis Potosí, Mexico 2. Dpto. Inmunología. Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Circuito Escolar, Ciudad Universitaria, 04510, Mexico, D.F., Mexico 3. Facultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Mexico 4. Dpto. de Parasitología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220, Madrid, Spain
Main conclusion The Taenia solium HP6/TSOL18 antigen was produced in carrot cells, yielding an immunogenic protein that induced significant protection in an experimental murine model against T. crassiceps cysticercosis when orally administered. This result supports the potential of HP6/TSOL18-carrot as a low-cost anti-cysticercosis vaccine candidate.